Jesse M. Hunter, PhD, FACMG

Jesse Hunter, PhD, FACMG, completed his B.S. and M.S. degrees in Biochemistry at Brigham Young University followed by a Ph.D. at the University of Alabama at Birmingham in Cell Biology. He completed a Laboratory Genetics and Genomics fellowship at the Wisconsin State Laboratory of Hygiene in 2020 and and is board certified in Laboratory Genetics and Genomics (2021). Dr. Hunter was employed by Translational Genomics Research Institute and Ambry Genetics where he gained expertise in research and clinical whole exome sequencing (WES) and analysis.

Dr. Hunter joined Nationwide Children’s Hospital as a Clinical Laboratory Director in the Institute for Genomic Medicine in 2020 where he has focused on bringing cutting edge genome sequencing to Nationwide Children's. He has been a key driver in bringing Rapid Genome Sequencing online as a clinically orderable test with preliminary results in 5 days. These tests provide the most comprehensive genetic analysis available bringing personalized medicine to the Nationwide Children's NICU and to Nationwide Children's genetics patients. Dr. Hunter is also applying his expertise and knowledge in constitutional genome sequencing in the research setting as a member of the Nationwide Children's Rare Disease steering committee.

In addition to his efforts within Nationwide Children's, Dr. Hunter is also developing a national and international reputation. He a committee co-chair for the diagnostic odyssey committee of National Organization for Rare Disease (NORD). In this role he is working with the committee to reduce the diagnostic odyssey through identifying obstacles to care for those suspected or diagnosed with a rare disease and proposing resolutions to those obstacles. Additionally, Dr. Hunter participates in several working groups for the Ethical, Legal, and Social, and Issues (ELSI) Committee for ACMG.